Cargando…

Phosphatidylserine-targeting antibody induces M1 macrophage polarization, promotes myeloid derived suppressor cell differentiation and boosts tumor-specific immunity

Detalles Bibliográficos
Autores principales:	Huang, Xianming, Yin, Yi, Ye, Dan, Brekken, Rolf, Thorpe, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991226/ http://dx.doi.org/10.1186/2051-1426-1-S1-P154

Ejemplares similares

Antibody-mediated phosphatidylserine blockade significantly enhances the efficacy of downstream immune checkpoint inhibition in K1735 mouse melanoma
por: Huang, Xianming, et al.
Publicado: (2014)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Targeting phosphatidylserine synergizes with immune checkpoint blockade by inducing de novo tumor specific immunity
por: Huang, Xianming, et al.
Publicado: (2015)

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
por: Belzile, Olivier, et al.
Publicado: (2018)

Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies
por: Sharma, Raghava, et al.
Publicado: (2017)

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors
por: Gong, Jian, et al.
Publicado: (2014)

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
por: Gong, Jian, et al.
Publicado: (2013)

Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma
por: Yopp, Adam, et al.
Publicado: (2014)

Soy-derived Phosphatidic Acid, Lysophosphatidic acid and Phosphatidylserine are sufficient to induce an increase in mTOR signaling
por: Gundermann, David M, et al.
Publicado: (2013)

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
por: Mao, Yumeng, et al.
Publicado: (2014)

Dendritic cells inhibit myeloid-derived suppressor cells infiltration and function in mouse B16 melanoma microenvironment
por: Xia, Siyuan, et al.
Publicado: (2013)

A method for non-overlapping identification of human myeloid derived suppressor cells
por: Gustafson, Michael, et al.
Publicado: (2014)

Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells
por: Medina-Echeverz, Jose, et al.
Publicado: (2013)

Motolimod, a selective TLR8 agonist induces apoptosis in monocytic myeloid-derived suppressor cells (M-MDSC)
por: Rutnam, Zina J, et al.
Publicado: (2015)

Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771
por: Gray, Michael, et al.
Publicado: (2015)

HIV-1 infection in polarized primary macrophages
por: Cobos-Jiménez, Viviana, et al.
Publicado: (2011)

Interrogating the interactions between myeloid derived suppressor cells and cancer stem cells in glioblastoma
por: Otvos, Balint, et al.
Publicado: (2013)

0097. Myeloid-derived suppressor cells attenuate inflammation and improve the survival of microbial sepsis
por: Tong, L, et al.
Publicado: (2014)

ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth
por: Kohanbash, Gary, et al.
Publicado: (2014)

Inhibiting Growth of Human Triple-Negative Breast Cancer Cells by Activating Mutant p53 Protein Alone or in Combination With a Phosphatidylserine-Targeting Antibody
por: Liang, Yayun, et al.
Publicado: (2021)

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
por: Vollbrecht, T, et al.
Publicado: (2012)

Bone marrow-derived progenitor cells develop into myeloid-derived suppressor cells at metastatic sites
por: Giles, Amber, et al.
Publicado: (2013)

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells
por: Chang, Alan L, et al.
Publicado: (2015)

Identification of distinct polarized macrophage subsets in inflammatory arthritis
por: Ambarus, C, et al.
Publicado: (2010)

Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts
por: Raber, Patrick L, et al.
Publicado: (2013)

Dynamic regulation of macrophage polarization via coupled multicellular networks
por: Chuang, Yishan, et al.
Publicado: (2013)

The effects of phosphatidylserine supplementation on cognitive functioning prior and following an acute bout of resistance training in young males
por: Parker, Adam, et al.
Publicado: (2010)

High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases
por: Janols, H, et al.
Publicado: (2014)

Proangiogenic neutrophilic-myeloid-derived suppressor cells emerge via two parallel pathways in renal cell carcinoma and melanoma
por: Ko, Jennifer, et al.
Publicado: (2013)

Protective Effect of Anti-Phosphatidylserine Antibody in a Guinea Pig Model of Advanced Hemorrhagic Arenavirus Infection
por: Thomas, John M., et al.
Publicado: (2017)

Study of circulating myeloid derived suppressor cells (MDSC) in patients with breast cancer undergoing neo-adjuvant chemotherapy; interim results
por: Wesolowski, Robert, et al.
Publicado: (2013)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
por: Eissler, Nina, et al.
Publicado: (2014)

APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice
por: Liang, Yayun, et al.
Publicado: (2019)

Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors
por: Highfill, Steven L, et al.
Publicado: (2013)

SUN-LB055 Targeting Mutant p53 Alone or in Combination with a Phosphatidylserine Specific Antibody Suppresses Growth and Metastasis of Human Breast Cancer: A Strategy Towards Enhancing Personalized Medicine
por: Liang, Yayun, et al.
Publicado: (2019)

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells
por: Payne, Kyle K, et al.
Publicado: (2013)

Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytes
por: Younis, Rania H, et al.
Publicado: (2015)

Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients
por: Md Sakib Hossain, Dewan, et al.
Publicado: (2014)

E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost
por: Hutnick, NA, et al.
Publicado: (2012)

Frequencies of circulating myeloid derived suppressor cells and dendritic cells in Egyptian patients with chronic Hepatitis C Virus infection undergoing treatment with IFN-α-based therapy
por: Salem, Mohamed L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_75tqn94s3sjtkk59i3g9g4la93